Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries
Video Oct 06, 2016
Throughout your lifetime, your brain continuously revises its own wiring. This ability of the brain to change and adapt is referred to as neuroplasticity (neuro = neuron, plasticity = the malleability of the brain). Here to explain precisely what neuroplasticity is, how it happens and how we can harness it, is one of the world's leading minds in this area – Dr Michael Merzenich.WATCH NOW
Urinalysis has long been a staple of physical exams to detect and manage a number of diseases and disorders, but not cancer. What if it were that easy, though, and cancer was detected in its very earliest stages when the disease responds more favorably to treatment and improved outcomes are more likely?WATCH NOW